Optimal Tissue Size for Successful Cytogenetic Yield in Lymphoma Work-Up

Nina Haghi^1, , Hua Guo¹, Sujata Sajjan¹, Pooja Navale¹, Haris Sheikh¹, Neha Gupta¹, Ninette Cohen¹, Judith Brody¹, Tawfiqul A Bhuiya¹ and Silvat Sheikh-Fayyaz^1,

¹Department of Pathology and Laboratory Medicine, Northwell Health, 2200 Northern Blvd, Greenvale, NY 11548

Cite this paper:
Nina Haghi, Hua Guo, Sujata Sajjan, Pooja Navale, Haris Sheikh, Neha Gupta, Ninette Cohen, Judith Brody, Tawfiqul A Bhuiya and Silvat Sheikh-Fayyaz. Optimal Tissue Size for Successful Cytogenetic Yield in Lymphoma Work-Up. International Journal of Hematological Disorders. 2020; 4(1):1-3. doi: 10.12691/ijhd-4-1-1

Abstract

The work-up of suspected lymphoma involves conventional cytogenetic analysis for diagnostic and prognostic purposes. Definitive guidelines specifying the size or quantity of tissue needed to yield successful cytogenetic results are lacking, and significant variation in the success rate is routinely observed. Our study aims to describe one medical center’s experience with cytogenetic analysis of specimens submitted for lymphoma work-up and assess the optimal quantity of tissue required to yield successful cytogenetic analysis. 417 cases of suspected lymphoma over a two-year period that were submitted for cytogenetic analysis at Long Island Jewish Medical Center and North Shore Hospital were reviewed. Proportions of lymphoma and non-lymphoma cases as well as failed and successful analyses were evaluated. Specimen size measurements were reviewed to characterize how tissue size impacts cytogenetic analysis yield. 209 lymphoma and 208 non-lymphoma cases were identified. 52% of lymphoma cases and 58% of non-lymphoma cases had failed cytogenetic analysis. Size cutoff value to produce a successful cytogenetic analysis was determined to be 0.2 cm³ (p=0.022). More than half of specimens submitted for lymphoma work-up yielded a failed study. We found that specimens submitted for analysis that were at least 0.2 cm³ produced successful results. We hope to make providers aware of the importance of submitting adequate biopsy material to ensure yield and avoid repeat biopsy.

Keywords:
lymphoma biopsy cytogenetic analysis tissue adequacy

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Cook JR, Shekhter-Levin S, Swerdlow SH. Utility of routine classical cytogenetic studies in the evaluation of suspected lymphomas: Results of 279 consecutive lymph node/extranodal tissue biopsies. American Journal of Clinical Pathology. 2004.
[2]	Dunphy CH, Tang W. Usefulness of routine conventional cytogenetic analysis in tissues submitted for “lymphoma work-up.” Leukemia and Lymphoma. 2008.
[3]	Swerdlow SH, Campo E, Harris NL, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016; 127(3): 2375-2390.
[4]	Arsham MS, Shaffer LG. ISCN: the universal language of cytogenetics. In: The AGT Cytogenetics Laboratory Manual. 2017.
[5]	Zneimer SM. Cytogenetic Abnormalities: Chromosomal, FISH and Microarray-Based Clinical Reporting. 2014.
[6]	Simons A, Shaffer LG, Hastings RJ. Cytogenetic nomenclature: Changes in the ISCN 2013 compared to the 2009 edition. Cytogenetic and Genome Research. 2013.
[7]	Hastings RJ, Bown N, Tibiletti MG, et al. Guidelines for cytogenetic investigations in tumours. European Journal of Human Genetics. 2016.